Moderate Daily Intake of Red Wine Inhibits Mural Thrombosis and Monocyte Tissue Factor Expression in an Experimental Porcine Model

Abstract

Background-Moderate consumption of red wine has been epidemiologically associated with a reduction in cardiovascular disease, but its mechanism of action is not fully understood. The objective was to study whether the protective effects of a daily intake of red wine (Tempranillo, 12.8% alcohol vol/vol) could be related to inhibition of thrombosis in an experimental model of diet-induced hyperlipemia. Methods and Results-For 100 days, animals were fed a western-type proatherogenic diet containing 2% cholesterol and 20% saturated fat. Three doses of red wine were studied (20, 30, and 40 g wine-ethanol/d) and compared with placebo-control animals not taking any wine. Thrombosis under flow conditions was evaluated by radioisotopic quantification of deposited platelets on damaged arteries. Changes in RhoA translocation in platelets and monocyte tissue factor expression were also analyzed. Mural platelet deposition was significantly reduced in animals ingesting red wine with their food. Expression of RhoA in the platelet cytoplasm (inactive form) was increased in wine-fed animals.Tissue factor mRNA expression in lipopolysaccharide-stimulated monocytes was reduced in wine-fed animals. Total cholesterol levels were not significantly different among groups. Conclusions-Moderate red wine intake significantly reduces platelet deposition triggered by damaged vessel wall, partially explained by inhibition of RhoA translocation to the platelet membrane. Hence, a daily moderate intake of wine seems to inhibit different pathways that converge in a reduced thrombotic risk on vessel wall injury.

Alcohol and the heart: To abstain or not to abstain?

“…[128] Potential protective mechanisms beyond the effects of ethanol include, greater anti-oxidant effects, [129][130][131] decreased erythrocyte superoxide dismutase activity, [132] and in vitro studies showing reduced vascular smooth muscle cells proliferation, [133] vasorelaxation of human coronary arteries, [134] inhibition of endothelin-1 synthesis, [135] and down-regulation of tissue factor (TF) gene transcription. [136] Alcohol and Heart Failure Moderate alcohol consumption was associated with a lower risk of incident heart failure among older adults and in the Physicians' Health Study, independent of a number of confounding factors. Further, it did not appear to be mediated by a reduction in MI risk, after an extended follow-up of 18 years.…”

When an enemy becomes a friend. On the benefits of alcohol consumption

“…В испанской популяции пиво и крепкие напитки, но не вино ассоциировались с развитием артериальной гипертензии независимо от стиля потребле-ния [85]. Помимо антиоксидантного действия, испытания in vitro обнаружили такие позитивные эффекты вина, как подавление пролиферации гладкомышечных клеток сосу-дов [86], релаксацию коронарных артерий [87], ингибиро-вание синтеза эндотелина-1 [88] и транскрипции гена моноцитарного тканевого фактора [89].…”

Tissue factor in the antiphospholipid syndrome

“…92,93 Second, a daily moderate amount of red wine inhibited thrombosis and monocyte TF expression in an animal model. 94 Conclusion TF is the physiological initiator of normal blood coagulation and the proximate trigger in many types of thrombotic disease. Both in vitro and in vivo data suggest that the intravascular expression of TF plays an important role in the pathophysiology of APS.…”